Back to top
more

Canopy Growth (CGC)

(Real Time Quote from BATS)

$7.76 USD

7.76
4,746,646

+0.63 (8.84%)

Updated Jul 22, 2024 01:25 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value A Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (76 out of 250)

Industry: Medical - Products

Better trading starts here.

Zacks News

Canopy Growth Corporation (CGC) Registers a Bigger Fall Than the Market: Important Facts to Note

Canopy Growth Corporation (CGC) closed the most recent trading day at $7.13, moving -1.25% from the previous trading session.

Canopy Growth Corporation (CGC) Advances But Underperforms Market: Key Facts

In the closing of the recent trading day, Canopy Growth Corporation (CGC) stood at $6.50, denoting a +0.31% change from the preceding trading day.

Canopy Growth Corporation (CGC) Surpasses Market Returns: Some Facts Worth Knowing

Canopy Growth Corporation (CGC) reachead $6.67 at the closing of the latest trading day, reflecting a +0.6% change compared to its last close.

Canopy Growth Corporation (CGC) is Attracting Investor Attention: Here is What You Should Know

Zacks.com users have recently been watching Canopy Growth (CGC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Canopy Growth Corporation (CGC) Is a Trending Stock: Facts to Know Before Betting on It

Zacks.com users have recently been watching Canopy Growth (CGC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Are Medical Stocks Lagging Arcutis Biotherapeutics (ARQT) This Year?

Here is how Arcutis Biotherapeutics, Inc. (ARQT) and Canopy Growth Corporation (CGC) have performed compared to their sector so far this year.

Canopy Growth Corporation (CGC) Reports Q4 Loss, Tops Revenue Estimates

Canopy Growth (CGC) delivered earnings and revenue surprises of 15.15% and 2.43%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Moumi Mondal headshot

Should You Buy Canopy Growth (CGC) Ahead of Q4 Earnings?

Canopy Growth's (CGC) rightsized cannabis-focused business is a major foundation for growth.

Canopy Growth Corporation (CGC) Rises Higher Than Market: Key Facts

In the closing of the recent trading day, Canopy Growth Corporation (CGC) stood at $9.18, denoting a +0.77% change from the preceding trading day.

Will Canopy Growth Corporation (CGC) Report Negative Earnings Next Week? What You Should Know

Canopy Growth (CGC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Medtronic (MDT) Q4 Earnings and Revenues Surpass Estimates

Medtronic (MDT) delivered earnings and revenue surprises of 0.69% and 1.80%, respectively, for the quarter ended April 2024. Do the numbers hold clues to what lies ahead for the stock?

Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: Here's Why

Canopy Growth Corporation (CGC) concluded the recent trading session at $10.85, signifying a -1.36% move from its prior day's close.

Investors Heavily Search Canopy Growth Corporation (CGC): Here is What You Need to Know

Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Strength Seen in Canopy Growth (CGC): Can Its 11.0% Jump Turn into More Strength?

Canopy Growth (CGC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Canopy Growth Corporation (CGC) Stock Declines While Market Improves: Some Information for Investors

The latest trading day saw Canopy Growth Corporation (CGC) settling at $10.24, representing a -0.97% change from its previous close.

Is Boston Scientific (BSX) Outperforming Other Medical Stocks This Year?

Here is how Boston Scientific (BSX) and Canopy Growth Corporation (CGC) have performed compared to their sector so far this year.

Do Options Traders Know Something About Canopy Growth (CGC) Stock We Don't?

Investors need to pay close attention to Canopy Growth (CGC) stock based on the movements in the options market lately.

Canopy Growth Corporation (CGC) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Canopy Growth Corporation (CGC) closed the most recent trading day at $4.79, moving -0.83% from the previous trading session.

ResMed (RMD) Tops Q2 Earnings and Revenue Estimates

ResMed (RMD) delivered earnings and revenue surprises of 3.87% and 0.46%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Canopy Growth Corporation (CGC) Outperforms Broader Market: What You Need to Know

Canopy Growth Corporation (CGC) reachead $4.41 at the closing of the latest trading day, reflecting a +0.92% change compared to its last close.

Canopy Growth Corporation (CGC) Stock Drops Despite Market Gains: Important Facts to Note

In the most recent trading session, Canopy Growth Corporation (CGC) closed at $4.56, indicating a -0.87% shift from the previous trading day.

Canopy Growth Corporation (CGC) Gains As Market Dips: What You Should Know

The latest trading day saw Canopy Growth Corporation (CGC) settling at $4.86, representing a +1.46% change from its previous close.

Zacks Market Edge Highlights: Canopy Growth, Tilray Brands, Constellation Brands, Innovative Industrial Properties and Jazz Pharmaceuticals

Canopy Growth, Tilray Brands, Constellation Brands, Innovative Industrial Properties and Jazz Pharmaceuticals are part of the Zacks Market Edge blog.

Tracey Ryniec headshot

Pot Stocks: Values or Traps?

Pot stocks used to be hot but many have plunged over the last 2 years. Are there deals?

Canopy Growth Corporation (CGC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Canopy Growth Corporation (CGC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.